https://www.selleckchem.com/pr....oducts/CP-690550.htm
We aimed to investigate the validity of urinary N-terminal titin fragment as a biomarker for amyotrophic lateral sclerosis (ALS). We consecutively enrolled patients with ALS (n=7 and healthy controls (HC) (n=43). We assessed the urinary titin N-terminal fragment, urinary neurotrophin receptor p75 extracellular domain, serum neurofilament light chain (NfL), motor functional measurements and prognosis. We used urinary creatinine (Cr) levels to normalise the urinary levels of titin fragment. Compared with HC, patients with ALS had sign
Like
Comment
Share
